CF
DRTS icon

Cantor Fitzgerald’s Alpha Tau Medical DRTS Stock Holding History

Cantor Fitzgerald’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,000
Closed -$34.1K – 345
2024
Q4 		$34.1K Hold
11,000
– – ﹤0.01% 231
2024
Q3 		$26.2K Buy
+11,000
New +$24.3K ﹤0.01% 173

Other funds holding DRTS

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SAM
Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cantor Fitzgerald's DRTS Position: Q1 2025 in Review

Cantor Fitzgerald sold out of Alpha Tau Medical (DRTS) in Q1 2025, closing a stake of 11,000 shares — an estimated $34.1K sold.

Cantor Fitzgerald first reported a position in DRTS in Q3 2024 and held it in 2 quarters. The position peaked at $34.1K in Q4 2024. 23 funds tracked by Wall St. Rank hold DRTS as of Q1 2025.

  • Cantor Fitzgerald reported no remaining Alpha Tau Medical position as of Q1 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 11,000 Alpha Tau Medical shares in Q1 2025, an estimated $34.1K.
  • Cantor Fitzgerald first reported a position in Alpha Tau Medical in Q3 2024 and held it in 2 quarters.
  • Cantor Fitzgerald's Alpha Tau Medical position peaked at $34.1K in Q4 2024.
  • 23 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2025.

Based on Cantor Fitzgerald's 13F filing for Q1 2025, filed 15 May 2025.